These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35388464)

  • 1. Impact of Obesity on Postprandial Triglyceride Contribution to Glucose Homeostasis, Assessed with a Semimechanistic Model.
    Leohr J; Kjellsson MC
    Clin Pharmacol Ther; 2022 Jul; 112(1):112-124. PubMed ID: 35388464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of postprandial total triglycerides within the TIGG model for characterizing postprandial response of glucose, insulin, and GLP-1.
    Leohr J; Kjellsson MC
    CPT Pharmacometrics Syst Pharmacol; 2023 Oct; 12(10):1529-1540. PubMed ID: 37667531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-physiological model of postprandial triglyceride response in lean, obese and very obese individuals after a high-fat meal.
    Leohr J; Heathman M; Kjellsson MC
    Diabetes Obes Metab; 2018 Mar; 20(3):660-666. PubMed ID: 29072819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
    Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial triglyceride reduction following acute treatment of a selective 5-hydroxytryptamine-2c agonist and characterization using a semi-physiological model.
    Leohr J; Heathman M; Kjellsson MC
    Diabetes Obes Metab; 2021 Apr; 23(4):1001-1010. PubMed ID: 33368960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial.
    Smith K; Taylor GS; Allerton DM; Brunsgaard LH; Bowden Davies KA; Stevenson EJ; West DJ
    Front Endocrinol (Lausanne); 2021; 12():696977. PubMed ID: 34220720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
    Verdich C; Toubro S; Buemann B; Lysgård Madsen J; Juul Holst J; Astrup A
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1206-14. PubMed ID: 11477506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects.
    Shah M; Franklin B; Adams-Huet B; Mitchell J; Bouza B; Dart L; Phillips M
    Eur J Nutr; 2017 Apr; 56(3):1053-1062. PubMed ID: 26759261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed clearance of triglyceride-rich lipoproteins in young, healthy obese subjects.
    Larsen MA; Goll R; Lekahl S; Moen OS; Florholmen J
    Clin Obes; 2015 Dec; 5(6):349-57. PubMed ID: 26469529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial.
    Vors C; Pineau G; Drai J; Meugnier E; Pesenti S; Laville M; Laugerette F; Malpuech-Brugère C; Vidal H; Michalski MC
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3427-35. PubMed ID: 26151336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats.
    Nakajima S; Hira T; Hara H
    Br J Nutr; 2015 May; 113(9):1477-88. PubMed ID: 25827219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneously obese dogs exhibit greater postprandial glucose, triglyceride, and insulin concentrations than lean dogs.
    Verkest KR; Rand JS; Fleeman LM; Morton JM
    Domest Anim Endocrinol; 2012 Feb; 42(2):103-12. PubMed ID: 22130330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients.
    Guerci B; Vergès B; Durlach V; Hadjadj S; Drouin P; Paul JL
    Int J Obes Relat Metab Disord; 2000 Apr; 24(4):468-78. PubMed ID: 10805504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
    Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels.
    Skrapari I; Perrea D; Ioannidis I; Karabina SA; Elisaf M; Tselepis AD; Karagiannacos P; Katsilambros N
    Diabet Med; 2001 Oct; 18(10):781-5. PubMed ID: 11678967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
    Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
    Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meal-derived glucagon responses are related to lower hepatic phosphate concentrations in obesity and type 2 diabetes.
    Weber KS; Straßburger K; Fritsch M; Bierwagen A; Koliaki C; Phielix E; Pacini G; Hwang JH; Markgraf DF; Burkart V; Müssig K; Szendroedi J; Roden M
    Diabetes Metab; 2018 Nov; 44(5):444-448. PubMed ID: 29910091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior exercise and postprandial incretin responses in lean and obese individuals.
    Heden TD; Liu Y; Kearney ML; Park Y; Dellsperger KC; Thomas TR; Kanaley JA
    Med Sci Sports Exerc; 2013 Oct; 45(10):1897-905. PubMed ID: 23559122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.